{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T22:25:54Z","timestamp":1787178354927,"version":"build-2736575974"},"reference-count":131,"publisher":"Frontiers Media SA","funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL056643, R01HL092514"],"award-info":[{"award-number":["R01HL056643, R01HL092514"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2016.00650","type":"journal-article","created":{"date-parts":[[2016,12,23]],"date-time":"2016-12-23T20:48:11Z","timestamp":1482526091000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Autologous and Allogenous Antibodies in Lung and Islet Cell Transplantation"],"prefix":"10.3389","volume":"7","author":[{"given":"Deepak Kumar","family":"Nayak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prathab Balaji","family":"Saravanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandhya","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bashoo","family":"Naziruddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thalachallour","family":"Mohanakumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2016,12,23]]},"reference":[{"issue":"7","key":"B1","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1111\/j.1600-6143.2010.03143.x","article-title":"Combined pancreatic islet-lung transplantation: a novel approach to the treatment of end-stage cystic fibrosis","volume":"10","author":"Kessler","year":"2010","journal-title":"Am J Transplant"},{"issue":"8","key":"B2","doi-asserted-by":"publisher","first-page":"e0135385","DOI":"10.1371\/journal.pone.0135385","article-title":"Cell surface expression level variation between two common human leukocyte antigen alleles, HLA-A2 and HLA-B8, is dependent on the structure of the C terminal part of the alpha 2 and the alpha 3 domains","volume":"10","author":"Dellgren","year":"2015","journal-title":"PLoS One"},{"issue":"16","key":"B3","doi-asserted-by":"publisher","first-page":"9494","DOI":"10.1073\/pnas.95.16.9494","article-title":"The complete genomic sequence of 424,015 bp at the centromeric end of the HLA class I region: gene content and polymorphism","volume":"95","author":"Guillaudeux","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"B4","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1006\/geno.1998.5377","article-title":"The human major histocompatibility complex: 42,221 bp of genomic sequence, high-density sequence-tagged site map, evolution, and polymorphism for HLA class I","volume":"51","author":"Janer","year":"1998","journal-title":"Genomics"},{"issue":"1","key":"B5","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/jhg.2008.5","article-title":"The HLA genomic loci map: expression, interaction, diversity and disease","volume":"54","author":"Shiina","year":"2009","journal-title":"J Hum Genet"},{"issue":"Database issue","key":"B6","doi-asserted-by":"publisher","first-page":"D423","DOI":"10.1093\/nar\/gku1161","article-title":"The IPD and IMGT\/HLA database: allele variant databases","volume":"43","author":"Robinson","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"B7","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0065-230X(08)60724-1","article-title":"Some recent work on tumor immunity","volume":"4","author":"Gorer","year":"1956","journal-title":"Adv Cancer Res"},{"issue":"3","key":"B8","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1097\/00007890-196805000-00010","article-title":"Serotyping for homotransplantation. XII. Occurrence of cytotoxic antibodies following kidney transplantation in man","volume":"6","author":"Morris","year":"1968","journal-title":"Transplantation"},{"issue":"14","key":"B9","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1056\/NEJM196904032801401","article-title":"Significance of the positive crossmatch test in kidney transplantation","volume":"280","author":"Patel","year":"1969","journal-title":"N Engl J Med"},{"issue":"3","key":"B10","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1097\/TP.0b013e31817c4cb8","article-title":"Human leukocyte antigen antibodies and chronic rejection: from association to causation","volume":"86","author":"Terasaki","year":"2008","journal-title":"Transplantation"},{"issue":"6","key":"B11","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1097\/00007890-200209270-00011","article-title":"Development of an antibody specific to major histocompatibility antigens detectable by flow cytometry after lung transplant is associated with bronchiolitis obliterans syndrome","volume":"74","author":"Palmer","year":"2002","journal-title":"Transplantation"},{"issue":"2","key":"B12","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1097\/00007890-199601270-00016","article-title":"Immunologic monitoring in lung allograft recipients","volume":"61","author":"Schulman","year":"1996","journal-title":"Transplantation"},{"issue":"2","key":"B13","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/S0022-5223(97)70144-2","article-title":"Risk factors for the development of bronchiolitis obliterans syndrome after lung transplantation","volume":"114","author":"Kroshus","year":"1997","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"5","key":"B14","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1097\/00007890-199803150-00008","article-title":"HLA-A locus mismatches and development of antibodies to HLA after lung transplantation correlate with the development of bronchiolitis obliterans syndrome","volume":"65","author":"Sundaresan","year":"1998","journal-title":"Transplantation"},{"issue":"8","key":"B15","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1097\/00007890-199904270-00012","article-title":"Development of ELISA-detected anti-HLA antibodies precedes the development of bronchiolitis obliterans syndrome and correlates with progressive decline in pulmonary function after lung transplantation","volume":"67","author":"Jaramillo","year":"1999","journal-title":"Transplantation"},{"issue":"10","key":"B16","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/j.healun.2003.08.030","article-title":"HLA-specific antibodies are associated with high-grade and persistent-recurrent lung allograft acute rejection","volume":"23","author":"Girnita","year":"2004","journal-title":"J Heart Lung Transplant"},{"issue":"1","key":"B17","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/j.1600-6143.2004.00650.x","article-title":"HLA-specific antibodies are risk factors for lymphocytic bronchiolitis and chronic lung allograft dysfunction","volume":"5","author":"Girnita","year":"2005","journal-title":"Am J Transplant"},{"issue":"1","key":"B18","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/j.1399-3046.2004.00270.x","article-title":"Immune mechanisms in the pathogenesis of bronchiolitis obliterans syndrome after lung transplantation","volume":"9","author":"Jaramillo","year":"2005","journal-title":"Pediatr Transplant"},{"issue":"12","key":"B19","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1016\/j.healun.2014.07.018","article-title":"De novo donor-specific HLA antibodies are associated with early and high-grade bronchiolitis obliterans syndrome and death after lung transplantation","volume":"33","author":"Morrell","year":"2014","journal-title":"J Heart Lung Transplant"},{"issue":"5","key":"B20","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1164\/rccm.201509-1857OC","article-title":"De novo DQ-donor-specific antibodies are associated with chronic lung allograft dysfunction after lung transplantation","volume":"194","author":"Tikkanen","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"B21","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.healun.2015.08.022","article-title":"Influence of human leukocyte antigen mismatching on bronchiolitis obliterans syndrome in lung transplantation","volume":"35","author":"Hayes","year":"2016","journal-title":"J Heart Lung Transplant"},{"issue":"1","key":"B22","doi-asserted-by":"publisher","first-page":"309","DOI":"10.4049\/jimmunol.182.1.309","article-title":"Antibodies to MHC class I induce autoimmunity: role in the pathogenesis of chronic rejection","volume":"182","author":"Fukami","year":"2009","journal-title":"J Immunol"},{"issue":"8","key":"B23","doi-asserted-by":"publisher","first-page":"e42370","DOI":"10.1371\/journal.pone.0042370","article-title":"Antibodies to MHC class II molecules induce autoimmunity: critical role for macrophages in the immunopathogenesis of obliterative airway disease","volume":"7","author":"Takenaka","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"B24","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.athoracsur.2008.03.073","article-title":"Immunological link between primary graft dysfunction and chronic lung allograft rejection","volume":"86","author":"Bharat","year":"2008","journal-title":"Ann Thorac Surg"},{"issue":"9","key":"B25","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.healun.2010.05.006","article-title":"Anti-human leukocyte antigen antibodies and preemptive antibody-directed therapy after lung transplantation","volume":"29","author":"Hachem","year":"2010","journal-title":"J Heart Lung Transplant"},{"issue":"6","key":"B26","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.healun.2011.01.708","article-title":"Alloimmunity-induced autoimmunity as a potential mechanism in the pathogenesis of chronic rejection of human lung allografts","volume":"30","author":"Saini","year":"2011","journal-title":"J Heart Lung Transplant"},{"issue":"12","key":"B27","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/j.healun.2014.06.015","article-title":"Early donor-specific antibodies in lung transplantation: risk factors and impact on survival","volume":"33","author":"Ius","year":"2014","journal-title":"J Heart Lung Transplant"},{"issue":"12","key":"B28","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1016\/j.healun.2014.07.012","article-title":"De novo donor HLA-specific antibodies predict development of bronchiolitis obliterans syndrome after lung transplantation","volume":"33","author":"Safavi","year":"2014","journal-title":"J Heart Lung Transplant"},{"issue":"4","key":"B29","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1097\/MOT.0b013e32833b31f4","article-title":"Alloimmunity and autoimmunity in chronic rejection","volume":"15","author":"Seetharam","year":"2010","journal-title":"Curr Opin Organ Transplant"},{"issue":"6","key":"B30","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.humimm.2010.02.021","article-title":"Development of antibodies to human leukocyte antigen precedes development of antibodies to major histocompatibility class I-related chain A and are significantly associated with development of chronic rejection after human lung transplantation","volume":"71","author":"Angaswamy","year":"2010","journal-title":"Hum Immunol"},{"issue":"7","key":"B31","doi-asserted-by":"publisher","first-page":"4487","DOI":"10.4049\/jimmunol.180.7.4487","article-title":"De novo production of K-alpha1 tubulin-specific antibodies: role in chronic lung allograft rejection","volume":"180","author":"Goers","year":"2008","journal-title":"J Immunol"},{"issue":"8","key":"B32","doi-asserted-by":"publisher","first-page":"5738","DOI":"10.4049\/jimmunol.181.8.5738","article-title":"Anti-type V collagen humoral immunity in lung transplant primary graft dysfunction","volume":"181","author":"Iwata","year":"2008","journal-title":"J Immunol"},{"issue":"4","key":"B33","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/j.athoracsur.2010.06.009","article-title":"Antibodies to self-antigens predispose to primary lung allograft dysfunction and chronic rejection","volume":"90","author":"Bharat","year":"2010","journal-title":"Ann Thorac Surg"},{"issue":"10","key":"B34","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1016\/j.healun.2013.07.004","article-title":"Acute antibody-mediated rejection after lung transplantation","volume":"32","author":"Witt","year":"2013","journal-title":"J Heart Lung Transplant"},{"issue":"8","key":"B35","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1111\/j.1600-6143.2012.04079.x","article-title":"Antibodies to K-alpha 1 tubulin and collagen V are associated with chronic rejection after lung transplantation","volume":"12","author":"Hachem","year":"2012","journal-title":"Am J Transplant"},{"issue":"10","key":"B36","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1111\/ajt.12908","article-title":"Immune response to tissue-restricted self-antigens induces airway inflammation and fibrosis following murine lung transplantation","volume":"14","author":"Subramanian","year":"2014","journal-title":"Am J Transplant"},{"issue":"6","key":"B37","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1034\/j.1600-6143.2003.00135.x","article-title":"Humoral theory of transplantation","volume":"3","author":"Terasaki","year":"2003","journal-title":"Am J Transplant"},{"issue":"5","key":"B38","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.coi.2005.07.018","article-title":"Humoral theory of transplantation: further evidence","volume":"17","author":"Terasaki","year":"2005","journal-title":"Curr Opin Immunol"},{"issue":"1","key":"B39","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1084\/jem.175.1.305","article-title":"Donor major histocompatibility complex (MHC) peptides are presented by recipient MHC molecules during graft rejection","volume":"175","author":"Benichou","year":"1992","journal-title":"J Exp Med"},{"issue":"1 Suppl","key":"B40","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1097\/01.tp.0000231347.06149.ca","article-title":"A novel pathway of antigen presentation by dendritic and endothelial cells: Implications for allorecognition and infectious diseases","volume":"82","author":"Smyth","year":"2006","journal-title":"Transplantation"},{"issue":"Pt 23","key":"B41","doi-asserted-by":"publisher","first-page":"4096","DOI":"10.1242\/jcs.091363","article-title":"Collagen V is a dominant regulator of collagen fibrillogenesis: dysfunctional regulation of structure and function in a corneal-stroma-specific Col5a1-null mouse model","volume":"124","author":"Sun","year":"2011","journal-title":"J Cell Sci"},{"issue":"6","key":"B42","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1097\/01.tp.0000258600.05531.5d","article-title":"Metalloproteinase inhibition has differential effects on alloimmunity, autoimmunity, and histopathology in the transplanted lung","volume":"83","author":"Yoshida","year":"2007","journal-title":"Transplantation"},{"issue":"3","key":"B43","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1097\/TP.0b013e31815e91b6","article-title":"Lung transplant ischemia reperfusion injury: metalloprotease inhibition down-regulates exposure of type V collagen, growth-related oncogene-induced neutrophil chemotaxis, and tumor necrosis factor-alpha expression","volume":"85","author":"Iwata","year":"2008","journal-title":"Transplantation"},{"issue":"3","key":"B44","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.4049\/jimmunol.169.3.1542","article-title":"Evidence for immune responses to a self-antigen in lung transplantation: role of type V collagen-specific T cells in the pathogenesis of lung allograft rejection","volume":"169","author":"Haque","year":"2002","journal-title":"J Immunol"},{"issue":"12","key":"B45","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1097\/TP.0b013e3181bcde7b","article-title":"Transfer of tolerance to collagen type V suppresses T-helper-cell-17 lymphocyte-mediated acute lung transplant rejection","volume":"88","author":"Braun","year":"2009","journal-title":"Transplantation"},{"issue":"1","key":"B46","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1165\/ajrcmb.25.1.4431","article-title":"Oral tolerance induction by type V collagen downregulates lung allograft rejection","volume":"25","author":"Yasufuku","year":"2001","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"4","key":"B47","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1097\/00007890-200202270-00002","article-title":"Prevention of bronchiolitis obliterans in rat lung allografts by type V collagen-induced oral tolerance","volume":"73","author":"Yasufuku","year":"2002","journal-title":"Transplantation"},{"issue":"11","key":"B48","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1136\/thoraxjnl-2016-208292","article-title":"Long-term persistence of human donor alveolar macrophages in lung transplant recipients","volume":"71","author":"Eguiluz-Gracia","year":"2016","journal-title":"Thorax"},{"issue":"8","key":"B49","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1111\/ajt.13819","article-title":"Long-term persistence of donor alveolar macrophages in human lung transplant recipients that influences donor-specific immune responses","volume":"16","author":"Nayak","year":"2016","journal-title":"Am J Transplant"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.13915","article-title":"Donor-derived exosomes with lung self-antigens in human lung allograft rejection","author":"Gunasekaran","year":"2016","journal-title":"Am J Transplant"},{"issue":"8","key":"B51","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.1172\/JCI84577","article-title":"Donor dendritic cell-derived exosomes promote allograft-targeting immune response","volume":"126","author":"Liu","year":"2016","journal-title":"J Clin Invest"},{"issue":"2","key":"B52","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1046\/j.1365-2567.1999.00866.x","article-title":"Differential modes of regulation of interleukin-1beta expression by extracellular matrices","volume":"98","author":"Roman","year":"1999","journal-title":"Immunology"},{"issue":"1","key":"B53","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1083\/jcb.200212079","article-title":"Regulated splicing of the fibronectin EDA exon is essential for proper skin wound healing and normal lifespan","volume":"162","author":"Muro","year":"2003","journal-title":"J Cell Biol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.redox.2016.02.005","article-title":"Lung extracellular matrix and redox regulation","volume":"8","author":"Watson","year":"2016","journal-title":"Redox Biol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.matbio.2013.08.003","article-title":"Collagen V localizes to pericellular sites during tendon collagen fibrillogenesis","volume":"33","author":"Smith","year":"2014","journal-title":"Matrix Biol"},{"issue":"5 Pt 1","key":"B56","first-page":"L924","article-title":"Clara cell secretory protein decreases lung inflammation after acute virus infection","volume":"275","author":"Harrod","year":"1998","journal-title":"Am J Physiol"},{"issue":"2","key":"B57","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.4049\/jimmunol.171.2.1051","article-title":"Clara cell secretory protein modulates lung inflammatory and immune responses to respiratory syncytial virus infection","volume":"171","author":"Wang","year":"2003","journal-title":"J Immunol"},{"issue":"2","key":"B58","doi-asserted-by":"publisher","first-page":"L383","DOI":"10.1152\/ajplung.00024.2007","article-title":"Clara cells impact the pulmonary innate immune response to LPS","volume":"293","author":"Elizur","year":"2007","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"31","key":"B59","doi-asserted-by":"publisher","first-page":"3429","DOI":"10.1038\/onc.2011.53","article-title":"Imbalance of clara cell-mediated homeostatic inflammation is involved in lung metastasis","volume":"30","author":"Tomita","year":"2011","journal-title":"Oncogene"},{"key":"B60","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1465-9921-15-45","article-title":"Association of serum clara cell protein CC16 with respiratory infections and immune response to respiratory pathogens in elite athletes","volume":"15","author":"Kurowski","year":"2014","journal-title":"Respir Res"},{"issue":"11","key":"B61","doi-asserted-by":"publisher","first-page":"3076","DOI":"10.1111\/j.1600-6143.2012.04201.x","article-title":"Epithelial clara cell injury occurs in bronchiolitis obliterans syndrome after human lung transplantation","volume":"12","author":"Kelly","year":"2012","journal-title":"Am J Transplant"},{"issue":"4","key":"B62","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.healun.2016.01.1223","article-title":"Antibody-mediated rejection of the lung: a consensus report of the International Society for Heart and Lung Transplantation","volume":"35","author":"Levine","year":"2016","journal-title":"J Heart Lung Transplant"},{"issue":"6","key":"B63","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.healun.2007.03.007","article-title":"Hyperacute rejection after lung transplantation caused by undetected low-titer anti-HLA antibodies","volume":"26","author":"Masson","year":"2007","journal-title":"J Heart Lung Transplant"},{"issue":"4","key":"B64","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1165\/rcmb.2016-0077OC","article-title":"Lung-restricted antibodies mediate primary graft dysfunction and prevent allo-tolerance following murine lung transplantation","volume":"55","author":"Bharat","year":"2016","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"1","key":"B65","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1513\/pats.200808-080GO","article-title":"Acute rejection and humoral sensitization in lung transplant recipients","volume":"6","author":"Martinu","year":"2009","journal-title":"Proc Am Thorac Soc"},{"issue":"2","key":"B66","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1055\/s-0030-1249113","article-title":"Acute cellular rejection and humoral sensitization in lung transplant recipients","volume":"31","author":"Martinu","year":"2010","journal-title":"Semin Respir Crit Care Med"},{"issue":"1","key":"B67","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.healun.2012.10.007","article-title":"Donor-specific antibodies are associated with antibody-mediated rejection, acute cellular rejection, bronchiolitis obliterans syndrome, and cystic fibrosis after lung transplantation","volume":"32","author":"Lobo","year":"2013","journal-title":"J Heart Lung Transplant"},{"issue":"4","key":"B68","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.4049\/jimmunol.180.4.2357","article-title":"HLA class I antibody-mediated endothelial cell proliferation via the mTOR pathway","volume":"180","author":"Jindra","year":"2008","journal-title":"J Immunol"},{"issue":"2","key":"B69","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1378\/chest.10-2838","article-title":"Bronchiolitis obliterans syndrome: the final frontier for lung transplantation","volume":"140","author":"Todd","year":"2011","journal-title":"Chest"},{"issue":"6","key":"B70","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1183\/09031936.00107514","article-title":"An international ISHLT\/ATS\/ERS clinical practice guideline: diagnosis and management of bronchiolitis obliterans syndrome","volume":"44","author":"Meyer","year":"2014","journal-title":"Eur Respir J"},{"issue":"2","key":"B71","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S1053-2498(01)00360-6","article-title":"Risk factors for bronchiolitis obliterans: a systematic review of recent publications","volume":"21","author":"Sharples","year":"2002","journal-title":"J Heart Lung Transplant"},{"issue":"2","key":"B72","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.healun.2013.10.022","article-title":"A new classification system for chronic lung allograft dysfunction","volume":"33","author":"Verleden","year":"2014","journal-title":"J Heart Lung Transplant"},{"issue":"5","key":"B73","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.healun.2014.11.007","article-title":"Restrictive chronic lung allograft dysfunction: where are we now?","volume":"34","author":"Verleden","year":"2015","journal-title":"J Heart Lung Transplant"},{"issue":"5","key":"B74","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1183\/09031936.00010615","article-title":"Linking clinical phenotypes of chronic lung allograft dysfunction to changes in lung structure","volume":"46","author":"Verleden","year":"2015","journal-title":"Eur Respir J"},{"issue":"9","key":"B75","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/j.healun.2016.03.022","article-title":"Predictors of survival in restrictive chronic lung allograft dysfunction after lung transplantation","volume":"35","author":"Verleden","year":"2016","journal-title":"J Heart Lung Transplant"},{"issue":"1","key":"B76","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.chest.2016.04.014","article-title":"Advances in understanding bronchiolitis obliterans after lung transplantation","volume":"150","author":"Verleden","year":"2016","journal-title":"Chest"},{"issue":"5","key":"B77","doi-asserted-by":"publisher","first-page":"L307","DOI":"10.1152\/ajplung.00378.2012","article-title":"The role of autoimmunity in obliterative bronchiolitis after lung transplantation","volume":"304","author":"Weber","year":"2013","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"9","key":"B78","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/j.healun.2014.04.020","article-title":"Efficacy of extracorporeal photopheresis in clearance of antibodies to donor-specific and lung-specific antigens in lung transplant recipients","volume":"33","author":"Baskaran","year":"2014","journal-title":"J Heart Lung Transplant"},{"issue":"1","key":"B79","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.healun.2014.09.019","article-title":"Preemptive treatment with therapeutic plasma exchange and rituximab for early donor-specific antibodies after lung transplantation","volume":"34","author":"Ius","year":"2015","journal-title":"J Heart Lung Transplant"},{"issue":"2","key":"B80","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1111\/ajt.13076","article-title":"Survival in sensitized lung transplant recipients with perioperative desensitization","volume":"15","author":"Tinckam","year":"2015","journal-title":"Am J Transplant"},{"issue":"8","key":"B81","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.healun.2013.01.187","article-title":"Pre-transplant antibodies to Kalpha1 tubulin and collagen-V in lung transplantation: clinical correlations","volume":"32","author":"Tiriveedhi","year":"2013","journal-title":"J Heart Lung Transplant"},{"issue":"1","key":"B82","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/TP.0b013e31827a19cc","article-title":"Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation","volume":"95","author":"Tait","year":"2013","journal-title":"Transplantation"},{"issue":"1","key":"B83","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1097\/00007890-198207000-00005","article-title":"Antigenic specificity of antibody reactive in the antiglobulin-augmented lymphocytotoxicity test","volume":"34","author":"Fuller","year":"1982","journal-title":"Transplantation"},{"issue":"3","key":"B84","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1111\/j.1365-2567.2010.03246.x","article-title":"Chronic rejection of a lung transplant is characterized by a profile of specific autoantibodies","volume":"130","author":"Hagedorn","year":"2010","journal-title":"Immunology"},{"issue":"7","key":"B85","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.2337\/dc15-1988","article-title":"Phase 3 trial of transplantation of human islets in type 1 diabetes complicated by severe hypoglycemia","volume":"39","author":"Hering","year":"2016","journal-title":"Diabetes Care"},{"issue":"6","key":"B86","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1097\/00000658-200306000-00001","article-title":"Insulin independence following isolated islet transplantation and single islet infusions","volume":"237","author":"Markmann","year":"2003","journal-title":"Ann Surg"},{"issue":"13","key":"B87","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1056\/NEJMoa061267","article-title":"International trial of the Edmonton protocol for islet transplantation","volume":"355","author":"Shapiro","year":"2006","journal-title":"N Engl J Med"},{"issue":"5","key":"B88","doi-asserted-by":"publisher","first-page":"901","DOI":"10.3727\/096368911X612468","article-title":"HLA class I sensitization in islet transplant recipients: report from the Collaborative Islet Transplant Registry","volume":"21","author":"Naziruddin","year":"2012","journal-title":"Cell Transplant"},{"issue":"12","key":"B89","doi-asserted-by":"publisher","first-page":"3239","DOI":"10.1111\/ajt.13407","article-title":"De novo donor-specific HLA antibodies are associated with rapid loss of graft function following islet transplantation in type 1 diabetes","volume":"15","author":"Brooks","year":"2015","journal-title":"Am J Transplant"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.3727\/096368916X691673","article-title":"Immunogenicity of anti-HLA antibodies in pancreas and islet transplantation","author":"Chaigne","year":"2016","journal-title":"Cell Transplant"},{"issue":"4","key":"B91","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1097\/TP.0b013e318195fc33","article-title":"Evidence for induced expression of HLA class II on human islets: possible mechanism for HLA sensitization in transplant recipients","volume":"87","author":"Jackson","year":"2009","journal-title":"Transplantation"},{"issue":"2","key":"B92","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1097\/01.tp.0000226161.82581.b2","article-title":"A significant role for histocompatibility in human islet transplantation","volume":"82","author":"Mohanakumar","year":"2006","journal-title":"Transplantation"},{"key":"B93","first-page":"413","article-title":"HLA sensitization in islet transplantation","author":"Rickels","year":"2006","journal-title":"Clin Transpl"},{"issue":"11","key":"B94","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1097\/01.tp.0000290388.70019.6e","article-title":"Allosensitization of islet allograft recipients","volume":"84","author":"Cardani","year":"2007","journal-title":"Transplantation"},{"issue":"10","key":"B95","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.1111\/j.1600-6143.2007.01923.x","article-title":"High risk of sensitization after failed islet transplantation","volume":"7","author":"Campbell","year":"2007","journal-title":"Am J Transplant"},{"issue":"5","key":"B96","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.2337\/db12-1258","article-title":"Alloantibody and autoantibody monitoring predicts islet transplantation outcome in human type 1 diabetes","volume":"62","author":"Piemonti","year":"2013","journal-title":"Diabetes"},{"issue":"1","key":"B97","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1097\/01.TP.0000133539.74599.0B","article-title":"Impact of donor-recipient MHC matching on experimental islet allotransplant survival in naive and presensitized Lewis rats","volume":"78","author":"Bittscheidt","year":"2004","journal-title":"Transplantation"},{"issue":"10","key":"B98","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.2337\/db09-0160","article-title":"Differences in baseline lymphocyte counts and autoreactivity are associated with differences in outcome of islet cell transplantation in type 1 diabetic patients","volume":"58","author":"Hilbrands","year":"2009","journal-title":"Diabetes"},{"issue":"1","key":"B99","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/j.1365-2249.2008.03812.x","article-title":"Relevance of cytotoxic alloreactivity under different immunosuppressive regimens in clinical islet cell transplantation","volume":"156","author":"Roelen","year":"2009","journal-title":"Clin Exp Immunol"},{"issue":"5","key":"B100","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1111\/j.1600-6143.2007.01777.x","article-title":"Pretransplant HLA antibodies are associated with reduced graft survival after clinical islet transplantation","volume":"7","author":"Campbell","year":"2007","journal-title":"Am J Transplant"},{"issue":"5","key":"B101","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.humimm.2005.01.018","article-title":"HLA incompatibility and immunogenicity of human pancreatic islet preparations cocultured with blood cells of healthy donors","volume":"66","author":"Bouwman","year":"2005","journal-title":"Hum Immunol"},{"issue":"3","key":"B102","doi-asserted-by":"publisher","first-page":"135","DOI":"10.2174\/1573399811666150317125820","article-title":"Monitoring inflammation, humoral and cell-mediated immunity in pancreas and islet transplants","volume":"11","author":"Monti","year":"2015","journal-title":"Curr Diabetes Rev"},{"issue":"4","key":"B103","doi-asserted-by":"publisher","first-page":"947","DOI":"10.2337\/db09-0498","article-title":"Recurrence of type 1 diabetes after simultaneous pancreas-kidney transplantation, despite immunosuppression, is associated with autoantibodies and pathogenic autoreactive CD4 T-cells","volume":"59","author":"Vendrame","year":"2010","journal-title":"Diabetes"},{"issue":"11","key":"B104","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.2337\/diabetes.46.11.1907","article-title":"Progressive islet graft failure occurs significantly earlier in autoantibody-positive than in autoantibody-negative IDDM recipients of intrahepatic islet allografts","volume":"46","author":"Jaeger","year":"1997","journal-title":"Diabetes"},{"issue":"6","key":"B105","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1097\/TP.0b013e31822ae65f","article-title":"Zinc transporter 8 autoantibodies increase the predictive value of islet autoantibodies for function loss of technically successful solitary pancreas transplant","volume":"92","author":"Occhipinti","year":"2011","journal-title":"Transplantation"},{"issue":"3","key":"B106","doi-asserted-by":"publisher","first-page":"484","DOI":"10.2337\/diabetes.48.3.484","article-title":"Auto- and alloimmune reactivity to human islet allografts transplanted into type 1 diabetic patients","volume":"48","author":"Roep","year":"1999","journal-title":"Diabetes"},{"issue":"6","key":"B107","doi-asserted-by":"publisher","first-page":"e2435","DOI":"10.1371\/journal.pone.0002435","article-title":"Cellular islet autoimmunity associates with clinical outcome of islet cell transplantation","volume":"3","author":"Huurman","year":"2008","journal-title":"PLoS One"},{"issue":"12","key":"B108","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.3727\/096368912X654993","article-title":"Emergence of a broad repertoire of GAD65-specific T-cells in type 1 diabetes patients with graft dysfunction after allogeneic islet transplantation","volume":"21","author":"Chujo","year":"2012","journal-title":"Cell Transplant"},{"issue":"5","key":"B109","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1172\/JCI35197","article-title":"Islet transplantation in patients with autoimmune diabetes induces homeostatic cytokines that expand autoreactive memory T cells","volume":"118","author":"Monti","year":"2008","journal-title":"J Clin Invest"},{"issue":"2","key":"B110","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1111\/j.1600-6143.2008.02479.x","article-title":"Allograft-specific cytokine profiles associate with clinical outcome after islet cell transplantation","volume":"9","author":"Huurman","year":"2009","journal-title":"Am J Transplant"},{"issue":"7","key":"B111","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.2337\/db09-1486","article-title":"Simultaneous detection of circulating autoreactive CD8+ T-cells specific for different islet cell-associated epitopes using combinatorial MHC multimers","volume":"59","author":"Velthuis","year":"2010","journal-title":"Diabetes"},{"issue":"Suppl","key":"B112","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/BF00275649","article-title":"Long-term effects of cyclosporin A on cultured mouse pancreatic islets","volume":"27","author":"Andersson","year":"1984","journal-title":"Diabetologia"},{"issue":"5","key":"B113","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.2337\/db05-1220","article-title":"Dexamethasone induces cell death in insulin-secreting cells, an effect reversed by exendin-4","volume":"55","author":"Ranta","year":"2006","journal-title":"Diabetes"},{"issue":"1","key":"B114","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/j.1432-2277.2008.00761.x","article-title":"Minimization and withdrawal of steroids in pancreas and islet transplantation","volume":"22","author":"Mineo","year":"2009","journal-title":"Transpl Int"},{"issue":"9","key":"B115","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.2337\/diab.35.9.1049","article-title":"Direct effects of cyclosporin A on human pancreatic beta-cells","volume":"35","author":"Nielsen","year":"1986","journal-title":"Diabetes"},{"issue":"9","key":"B116","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.2337\/diab.35.9.1016","article-title":"Cyclosporin-induced inhibition of insulin secretion in isolated rat islets and HIT cells","volume":"35","author":"Robertson","year":"1986","journal-title":"Diabetes"},{"issue":"4","key":"B117","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1056\/NEJM200007273430401","article-title":"Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen","volume":"343","author":"Shapiro","year":"2000","journal-title":"N Engl J Med"},{"issue":"9","key":"B118","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.2337\/db06-0173","article-title":"Sirolimus is associated with reduced islet engraftment and impaired beta-cell function","volume":"55","author":"Zhang","year":"2006","journal-title":"Diabetes"},{"issue":"7","key":"B119","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1097\/TP.0b013e31820c10c8","article-title":"Rapamycin impairs proliferation of transplanted islet beta cells","volume":"91","author":"Niclauss","year":"2011","journal-title":"Transplantation"},{"issue":"1","key":"B120","doi-asserted-by":"publisher","first-page":"42","DOI":"10.4161\/isl.1.1.8881","article-title":"Rapamycin does not adversely affect intrahepatic islet engraftment in mice and improves early islet engraftment in humans","volume":"1","author":"Melzi","year":"2009","journal-title":"Islets"},{"issue":"2","key":"B121","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1097\/00007890-198902000-00035","article-title":"Effect of a new immunosuppressive agent, FK506, on human lymphocyte responses in vitro. II. Inhibition of the production of IL-2 and gamma-IFN, but not B cell-stimulating factor 2","volume":"47","author":"Yoshimura","year":"1989","journal-title":"Transplantation"},{"issue":"7","key":"B122","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.2337\/diabetes.54.7.2060","article-title":"Five-year follow-up after clinical islet transplantation","volume":"54","author":"Ryan","year":"2005","journal-title":"Diabetes"},{"issue":"7","key":"B123","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.2337\/dc12-0063","article-title":"Improvement in outcomes of clinical islet transplantation: 1999-2010","volume":"35","author":"Barton","year":"2012","journal-title":"Diabetes Care"},{"issue":"6","key":"B124","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1111\/j.1600-6143.2011.03977.x","article-title":"Potent induction immunotherapy promotes long-term insulin independence after islet transplantation in type 1 diabetes","volume":"12","author":"Bellin","year":"2012","journal-title":"Am J Transplant"},{"issue":"12","key":"B125","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1097\/TP.0b013e3181fe1377","article-title":"Islet transplantation in type 1 diabetic patients using calcineurin inhibitor-free immunosuppressive protocols based on T-cell adhesion or costimulation blockade","volume":"90","author":"Posselt","year":"2010","journal-title":"Transplantation"},{"issue":"10","key":"B126","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.3727\/096368910X564058","article-title":"Improving efficacy of clinical islet transplantation with iodixanol based islet purification, thymoglobulin induction and blockage of IL-1-beta and TNF-alpha","volume":"20","author":"Matsumoto","year":"2011","journal-title":"Cell Transplant"},{"issue":"12","key":"B127","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1097\/TP.0000000000000396","article-title":"Calcineurin inhibitor-free immunosuppressive regimen in type 1 diabetes patients receiving islet transplantation: single-group phase 1\/2 trial","volume":"98","author":"Maffi","year":"2014","journal-title":"Transplantation"},{"issue":"4","key":"B128","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1097\/TP.0000000000000086","article-title":"Early alteration of kidney function in nonuremic type 1 diabetic islet transplant recipients under tacrolimus-mycophenolate therapy","volume":"98","author":"Gillard","year":"2014","journal-title":"Transplantation"},{"issue":"5","key":"B129","doi-asserted-by":"publisher","first-page":"752","DOI":"10.2337\/dc14-1686","article-title":"Glycemic control in simultaneous islet-kidney versus pancreas-kidney transplantation in type 1 diabetes: a prospective 13-year follow-up","volume":"38","author":"Lehmann","year":"2015","journal-title":"Diabetes Care"},{"issue":"6","key":"B130","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1097\/MOT.0b013e32834c2393","article-title":"Control of instant blood-mediated inflammatory reaction to improve islets of Langerhans engraftment","volume":"16","author":"Nilsson","year":"2011","journal-title":"Curr Opin Organ Transplant"},{"issue":"2","key":"B131","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3727\/096368912X658980","article-title":"Elevation of high-mobility group box 1 after clinical autologous islet transplantation and its inverse correlation with outcomes","volume":"23","author":"Itoh","year":"2014","journal-title":"Cell Transplant"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2016.00650\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,12,23]],"date-time":"2016-12-23T20:48:15Z","timestamp":1482526095000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2016.00650\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,23]]},"references-count":131,"URL":"https:\/\/doi.org\/10.3389\/fimmu.2016.00650","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,23]]}}}